Latest AI and machine learning research in prostate cancer for healthcare professionals.
BACKGROUND: A variety of biomarkers have been developed to monitor growth of cancerous diseases and to detect them at an early stage. Prostate-specific antigen (PSA) is a valuable prostate cancer biomarker that is now widely used for population screening, diagnosis, and monitoring of patients with prostate cancer. Other factors than prostate cancer can cause elevation of PSA levels therefore, free...
Detecting the presence of prostate cancer (PCa) and distinguishing low- or intermediate-risk disease from high-risk disease early, and without the need for potentially unnecessary invasive biopsies remains a significant clinical challenge. The aim of this study is to determine whether the T and B cell phenotypic features which we have previously identified as being able to distinguish between beni...
Magnetic resonance imaging (MRI) offers excellent soft-tissue contrast enabling the contouring of targets and organs at risk during gynecological inte...
In view of the growth of clinical risk prediction models using genetic data, there is an increasing need for studies that use appropriate methods to s...
INTRODUCTION: Modern image-guided biopsy pathways at diagnostic centres have greatly refined the investigations of men referred with suspected prostat...
Robot-assisted radical prostatectomy (RARP) is challenging in men with prior history of transurethral resection of the prostate (TURP). Few studies an...
OBJECTIVES: To evaluate the detection rate of clinically significant prostate cancer (csPCa) in Magnetic resonance imaging and ultrasonography (MRI/US...
PURPOSE: Automatic segmentation of medical images with deep learning (DL) algorithms has proven highly successful in recent times. With most of these ...
Psoriasis (Pso) is a chronic inflammatory skin disease, and up to 30% of Pso patients develop psoriatic arthritis (PsA), which can lead to irreversibl...
PURPOSE: High-dose-rate (HDR) prostate brachytherapy involves treatment catheter placement, which is currently empirical and physician dependent. The ...
This retrospective study has been conducted to validate the performance of deep learning-based survival models in glioblastoma (GBM) patients alongsid...
BACKGROUND AND PURPOSE: Accurate calculation of the absorbed dose delivered to the tumor and normal tissues improves treatment gain factor, which is t...
OBJECTIVES: To assess treatment response (PSA < 0.2 ng/ml), need for additional therapy and complication rate after robot assisted salvage pelvic lymp...
Achieving both high compliance and stiffness is a key issue in stiffness-tunable soft robots. A wide-range variable-stiffness method keeping pure soft...
OBJECTIVE: After radical prostatectomy, prostate-specific antigen(PSA) value measuring ≥0.1 ng/mL is defined as persistent PSA(pPSA) and in many studi...
This study aims to develop a deep learning-based strategy for treatment plan check and verification of high-dose rate (HDR) brachytherapy. A deep neur...
PURPOSE: Current prostate brachytherapy uses transrectal ultrasound images for implant guidance, where contours of the prostate and organs-at-risk are...
PURPOSE: Radioactive seed implantation is an effective invasive treatment method for malignant liver tumors in hepatocellular carcinomas. However, cha...
Artificial intelligence (AI) applications, in the form of machine learning and deep learning, are being incorporated into practice in various aspects ...
BACKGROUND AND PURPOSE: Delineation of organs at risk (OARs), such as the bladder, rectum and sigmoid, plays an important role in the delivery of opti...